SCHEMBL812403

SCHEMBL812403

CC1NC(=O)C(c2ccccc2-c2ccccc2Cl)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TNKS2 Q9H2K2 1/20 0.41
GAA P10253 1/20 0.35
PTPRC P08575 1/20 0.35
DPP4 P27487 2/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
PLA2G7 Q13093 1/20 0.34
CACNB4 O00305 1/20 0.34
CACNA1A O00555 1/20 0.34
CACNA1G O43497 1/20 0.34
CACNG3 O60359 1/20 0.34
CACNA1F O60840 1/20 0.34
CACNA1H O95180 1/20 0.34
CACNB3 P54284 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7098248 0.86 ELANE (0.36) SMN1; SMN2KDM4EALDH1A1HPGDTSHR
SCHEMBL6207995 0.72 PGR (0.40) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL812401 0.72 PGR (0.40) SMN1; SMN2ALDH1A1TNKS2GAABRPF1
SCHEMBL8650400 0.72 GAA (0.54) SMN1; SMN2KDM4EALDH1A1HPGDTSHR
SCHEMBL10814471 0.66 GPR119 (0.42) SMN1; SMN2KDM4EALDH1A1HPGDTSHR
SCHEMBL9126229 0.65 DPP4 (0.41) SMN1; SMN2KDM4EALDH1A1HPGDTSHR
SCHEMBL4433341 0.65 GAA (0.40) KDM4EALDH1A1HPGDGAAPOLB
SCHEMBL8712306 0.65 ALDH1A1 (0.41) SMN1; SMN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL6207998 0.64 ALDH1A1 (0.49) SMN1; SMN2KDM4EALDH1A1HPGDTSHR
SCHEMBL671133 0.63 CYP2A6 (0.67) SMN1; SMN2KDM4EALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058210-B2 Arylphenyl-substituted cyclic keto-enols BAYER CROPSCIENCE AG (DE) 2011-11-15 US disclosed
US-7718706-B2 Arylphenyl-substituted cyclic keto-enols BAYER AKTIENGESELLSCHAFT (DE) 2010-05-18 US disclosed
US-20100087320-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO-ENOLS LIEB FOLKER 2010-04-08 US disclosed
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols LIEB FOLKER 2008-04-03 US disclosed
US-7288676-B2 Arylphenyl-substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2007-10-30 US disclosed
US-7105471-B2 Arylphenyl-substituted cyclic ketoenols BAYER AKTIENGESELLSCHAFT (DE) 2006-09-12 US disclosed
US-20060122061-A1 Arylphenyl-substituted cyclic ketoenols LIEB FOLKER 2006-06-08 US disclosed
US-6806264-B2 PESTICIDES AND HERBICIDES; WOOD PROTECTANTS BAYER AKTIENGESELLSCHAFT (DE) 2004-10-19 US disclosed
US-20040127365-A1 Arylphenyl-substituted cyclic ketoenols LIEB FOLKER (DE) 2004-07-01 US disclosed
US-6716832-B2 PESTICIDES AND HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2004-04-06 US disclosed
US-6693092-B2 HERBICIDES; PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2004-02-17 US disclosed
US-20030073851-A1 Arylphenyl-substituted cyclic ketoenols LIEB FOLKER (DE) 2003-04-17 US disclosed
US-20020188136-A1 Arylphenyl-substituted cyclic ketoenols LIEB FOLKER (DE) 2002-12-12 US disclosed
US-6458965-B1 HERBICIDES, ANTIGROWTH AGENTS AND SURFACTANTS FOR WOOD PRESERVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2002-10-01 US disclosed
US-6417370-B1 HERBICIDES, PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2002-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122061-A1 Arylphenyl-substituted cyclic ketoenols KCNE1, KCNQ3, KCNQ2 SMN1; SMN2 4743/4885KDM4E 98/4885ALDH1A1 2523/4885
US-20030073851-A1 Arylphenyl-substituted cyclic ketoenols KCNE1, CYP2E1, CYP21A2 SMN1; SMN2 4667/4885KDM4E 148/4885ALDH1A1 1797/4885
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols KCNE1, DDT, KCNQ3 SMN1; SMN2 4753/4885KDM4E 81/4885ALDH1A1 2569/4885
US-20100087320-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO-ENOLS KCNE1, DDT, KCNQ3 SMN1; SMN2 4753/4885KDM4E 81/4885ALDH1A1 2569/4885
US-20040127365-A1 Arylphenyl-substituted cyclic ketoenols KCNE1, CYP2E1, CYP21A2 SMN1; SMN2 4667/4885KDM4E 148/4885ALDH1A1 1797/4885
US-20020188136-A1 Arylphenyl-substituted cyclic ketoenols KCNE1, CYP21A2, KCNQ3 SMN1; SMN2 4649/4885KDM4E 144/4885ALDH1A1 1648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.